What is the treatment for coagulase-negative Staphylococcus (CoNS) in urine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Coagulase-Negative Staphylococcus in Urine

In most cases, coagulase-negative staphylococci (CoNS) in urine should NOT be treated, as these organisms are typically contaminants or colonizers rather than true pathogens. 1

Determining Clinical Significance

The critical first step is distinguishing true infection from contamination or asymptomatic bacteriuria:

  • CoNS are "not considered clinically relevant urine isolates" in the majority of cases, particularly in asymptomatic patients 1
  • True infection requires both positive urine culture AND clinical symptoms (dysuria, frequency, urgency, suprapubic pain, fever) 1
  • Asymptomatic bacteriuria should NOT be treated except in pregnancy, to avoid unnecessary antibiotic use and resistance development 1

When Treatment IS Indicated

Treatment should be considered only when BOTH of the following are present:

Clinical Symptoms Present

  • Dysuria, frequency, urgency, or suprapubic pain for cystitis 1
  • Fever, flank pain, or systemic symptoms for pyelonephritis 1

High-Risk Features Present

  • Indwelling urinary catheter 2
  • Recent urological procedure 1
  • Immunocompromised status 1
  • Pregnancy 1

Antibiotic Selection When Treatment Is Warranted

For uncomplicated CoNS UTI, trimethoprim-sulfamethoxazole (TMP-SMX) or a fluoroquinolone is first-line therapy: 2

First-Line Options for Uncomplicated Cystitis:

  • TMP-SMX for 3 days (most appropriate for community-acquired CoNS) 1, 2
  • Nitrofurantoin for 5 days (alternative first-line option) 1
  • Fluoroquinolones (ciprofloxacin) when TMP-SMX cannot be used 2

For Pyelonephritis or Complicated UTI:

  • First-generation cephalosporin for 7 days 1
  • For systemic symptoms: amoxicillin plus aminoglycoside, second-generation cephalosporin plus aminoglycoside, or IV third-generation cephalosporin 1

For Methicillin-Resistant CoNS:

  • Vancomycin is reserved for documented methicillin-resistant strains or treatment failure 2
  • Linezolid is an alternative for patients who cannot tolerate vancomycin 2
  • Avoid cephalosporins even if in vitro testing suggests susceptibility, as cross-resistance exists 2

Treatment Duration

Duration depends on complexity and catheter presence:

  • Uncomplicated CoNS UTI: 5-7 days of appropriate antibiotic therapy 2
  • Complicated infections or catheter-associated: 10-14 days 2
  • If catheter is removed: 5-7 days of antibiotics 3
  • If catheter is retained: 10-14 days with antibiotic lock therapy 3

Catheter Management

Catheter removal is often more important than antibiotics:

  • Remove or replace urinary catheter when feasible 2
  • Catheter removal alone may resolve infection without antibiotics in some cases 2
  • If catheter cannot be removed, consider antibiotic lock therapy in addition to systemic antibiotics 2

Important Caveats

Common pitfalls to avoid:

  • Do not treat asymptomatic bacteriuria (except in pregnancy) to prevent antibiotic resistance 1
  • Always confirm CoNS is a true pathogen by assessing clinical symptoms and obtaining proper cultures 2
  • Treatment should be guided by antimicrobial susceptibility testing when available 1
  • Be aware that S. epidermidis shows higher resistance rates than S. saprophyticus to multiple antibiotics 4
  • Methicillin resistance is common in nosocomial CoNS isolates 5, 6

References

Guideline

Treatment of Urinary Tract Infection with Coagulase Negative Staphylococci

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Coagulase-Negative Staphylococcus in Urine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Coagulase-negative staphylococci: role as pathogens.

Annual review of medicine, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.